The REM Sleep Behavior Disorder Screening Questionnaire: Validation Study of the Korean Version (RBDQ-KR)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | You, Sooyeoun | - |
dc.contributor.author | Moon, Hye-Jin | - |
dc.contributor.author | Do, So Young | - |
dc.contributor.author | Wing, Yun-Kwok | - |
dc.contributor.author | Sunwoo, Jun-Sang | - |
dc.contributor.author | Jung, Ki-Young | - |
dc.contributor.author | Cho, Yong Won | - |
dc.date.accessioned | 2021-08-11T16:24:17Z | - |
dc.date.available | 2021-08-11T16:24:17Z | - |
dc.date.issued | 2017 | - |
dc.identifier.issn | 1550-9389 | - |
dc.identifier.issn | 1550-9397 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/8387 | - |
dc.description.abstract | Study Objectives: REM sleep behavior disorder (RBD) is a parasomnia that is commonly associated with neurodegenerative disorders. We aimed to validate the Hong Kong version of the self-reported RBD questionnaire (RBDQ-HK) with the Korean version (RBDQ-KR) and to investigate its clinical usefulness. Methods: One-hundred five patients with RBD and 105 age-and sex-matched controls were enrolled. Thirty were randomly selected for a retest with the questionnaire after 2 to 4 weeks without any treatment. Receiver operating characteristic curve and exploratory factor analysis were used to evaluate the scale, which had a score ranging from 0 to 100. Results: There was no difference in mean age and sex in patients with RBD and control subjects. Patients with RBD had a significantly higher total RBDQ-KR score than the control group (P <.001). The RBDQ-KR demonstrated high sensitivity (93.3%), specificity (89.5%), positive predictive value (89.9%), and negative predictive value (93.1%). Cronbach a coefficient for internal consistency of the total score of the RBDQ-KR was 0.9, which shows high reliability. Exploratory factor analysis showed two components, dream-related and behavioral factors, consistent with the main clinical features of RBD. Based on the results, the best cutoff for the total score ranging from 0 to 100 was at 18/19 and for factor 2 ranging from 0 to 75 was at 11. Conclusions: This study showed RBDQ-KR is a valid and reliable questionnaire for RBD symptoms and severity in Korea. It serves as an effective tool to identify patients with RBD and to facilitate future clinical and research studies. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | The American Academy of Sleep Medicine | - |
dc.title | The REM Sleep Behavior Disorder Screening Questionnaire: Validation Study of the Korean Version (RBDQ-KR) | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.5664/jcsm.6840 | - |
dc.identifier.scopusid | 2-s2.0-85039039762 | - |
dc.identifier.wosid | 000418069900009 | - |
dc.identifier.bibliographicCitation | Journal of Clinical Sleep Medicine, v.13, no.12, pp 1429 - 1433 | - |
dc.citation.title | Journal of Clinical Sleep Medicine | - |
dc.citation.volume | 13 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 1429 | - |
dc.citation.endPage | 1433 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
dc.subject.keywordPlus | HONG-KONG | - |
dc.subject.keywordPlus | NIGHTMARES | - |
dc.subject.keywordPlus | INDEX | - |
dc.subject.keywordAuthor | Korean | - |
dc.subject.keywordAuthor | questionnaire | - |
dc.subject.keywordAuthor | RBD | - |
dc.subject.keywordAuthor | reliability | - |
dc.subject.keywordAuthor | validity | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.